Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Validity of the Dynamic Gait Index in People With Multiple Sclerosis.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
Risk of fractures in patients with multiple sclerosis: A population-based cohort study.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.
Effects of fingolimod in relapsing-remitting multiple sclerosis.
Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis.
Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report.
The Impact of Increasing Multiple Sclerosis (Ms) Severity Level on Employment and Caregiver Burden.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
[The first results of a combined all-Russian study on clinical genetics of multiple sclerosis.]
The effects of identification with a support group on the mental health of people with multiple sclerosis.
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
Presence of aberrant V<formula>_{H}</formula>6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
Clarification on neuromuscular conditions in careers article.
Efficient in vivo depletion of CD8(+) T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration.
Pages
« first
‹ previous
…
325
326
327
328
329
330
331
332
333
…
next ›
last »